We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PFIZER REFUTES REPORTS OF ADDITIONAL CELEBREX DATA
PFIZER REFUTES REPORTS OF ADDITIONAL CELEBREX DATA
January 19, 2005
Pfizer’s top executives denied reports yesterday that the company’s fourth quarter earnings report contained references to additional clinical data that could be used to argue that its Cox-2 inhibitor Celebrex poses heart risks.